Literature DB >> 12937875

Xanthine oxidase activity is influenced by environmental factors in Ethiopians.

Eleni Aklillu1, Juan Antonio Carrillo, Eyasu Makonnen, Leif Bertilsson, Magnus Ingelman-Sundberg.   

Abstract

OBJECTIVES: To investigate xanthine oxidase (XO) polymorphism in Ethiopians and influence of environmental factors, smoking habit and gender-related differences on enzyme activity among Ethiopians living in Ethiopia or Sweden.
METHODS: One hundred healthy unrelated Ethiopians living in Ethiopia and 73 living in Sweden participated in the study. Subjects received a 100-mg oral dose of caffeine before bedtime. All urine voided in the following 8 h was collected and the concentrations of 1-methyluracil (1U) and 1-methylxanthine (1X) micromol/l) were analyzed by means of high-performance liquid chromatography. The 1U/(1X+1U) metabolic ratio (MR) was calculated and used as an index of XO activity.
RESULTS: XO activity was not normally distributed ( P<0.0001; Shapiro-Wilk's test). The incidence of putative XO poor metabolizers in Ethiopians was 4%. The effect of differences in country of residence, gender and smoking habit was analyzed using three-way ANOVA/MANOVA. The post-hoc test ( P<0.05) and Kruskal-Wallis ANOVA ( P<0.004), median test showed a significant difference in XO activity among Ethiopians living in Ethiopia compared with those living in Sweden, the activity being higher in Ethiopians living in Ethiopia. The 95% CI for differences between the two means was (0.012; 0.044). No significant difference was observed in XO MR between men and women or between smokers and non-smokers, the 95% CI for the differences being (-0.059; 0.037) and (-0.010; 0.016) respectively.
CONCLUSION: The XO activity is polymorphic in Ethiopians. Neither gender nor smoking-related differences influenced XO activity but the difference in activity between Ethiopians living in Sweden or in Ethiopia indicates influence of other environmental factors such as dietary habits on XO activity.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12937875     DOI: 10.1007/s00228-003-0653-8

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  25 in total

Review 1.  Flavoprotein structure and mechanism. 4. Xanthine oxidase and xanthine dehydrogenase.

Authors:  R Hille; T Nishino
Journal:  FASEB J       Date:  1995-08       Impact factor: 5.191

Review 2.  Myocardial reperfusion injury: role of oxygen radicals and potential therapy with antioxidants.

Authors:  M O Jeroudi; C J Hartley; R Bolli
Journal:  Am J Cardiol       Date:  1994-03-10       Impact factor: 2.778

3.  Xanthine oxidase catalyzed reductive cleavage of anthracycline antibiotics and free radical formation.

Authors:  S S Pan; N R Bachur
Journal:  Mol Pharmacol       Date:  1980-01       Impact factor: 4.436

4.  Xanthine oxidase activation in mild gestational hypertension.

Authors:  Ilona Németh; Gyula Tálosi; Andrea Papp; Domokos Boda
Journal:  Hypertens Pregnancy       Date:  2002       Impact factor: 2.108

5.  Interferons induce xanthine dehydrogenase gene expression in L929 cells.

Authors:  F Falciani; P Ghezzi; M Terao; G Cazzaniga; E Garattini
Journal:  Biochem J       Date:  1992-08-01       Impact factor: 3.857

6.  Xanthine dehydrogenase and xanthine oxidase activity and gene expression in renal epithelial cells. Cytokine and steroid regulation.

Authors:  K D Pfeffer; T P Huecksteadt; J R Hoidal
Journal:  J Immunol       Date:  1994-08-15       Impact factor: 5.422

7.  Racial and gender differences in N-acetyltransferase, xanthine oxidase, and CYP1A2 activities.

Authors:  M V Relling; J S Lin; G D Ayers; W E Evans
Journal:  Clin Pharmacol Ther       Date:  1992-12       Impact factor: 6.875

8.  Loss of fluorescence by anthracycline antibiotics: effects of xanthine oxidase and identification of the nonfluorescent metabolites.

Authors:  P Dodion; A L Bernstein; B M Fox; N R Bachur
Journal:  Cancer Res       Date:  1987-02-15       Impact factor: 12.701

9.  Allopurinol protects enterocytes from hypoxia-induced apoptosis in vivo.

Authors:  Ronald G Albuquerque; Angela J Sanson; Mark A Malangoni
Journal:  J Trauma       Date:  2002-09

10.  Genetic polymorphism of CYP1A2 in Ethiopians affecting induction and expression: characterization of novel haplotypes with single-nucleotide polymorphisms in intron 1.

Authors:  Eleni Aklillu; Juan Antonio Carrillo; Eyasu Makonnen; Karin Hellman; Marià Pitarque; Leif Bertilsson; Magnus Ingelman-Sundberg
Journal:  Mol Pharmacol       Date:  2003-09       Impact factor: 4.436

View more
  9 in total

1.  Serum and aqueous xanthine oxidase levels, and mRNA expression in anterior lens epithelial cells in pseudoexfoliation.

Authors:  Huseyin Simavli; Mehmet Tosun; Yasin Y Bucak; Mesut Erdurmus; Zeynep Ocak; Halil I Onder; Muradiye Acar
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2015-05-10       Impact factor: 3.117

2.  Distribution of xanthine oxidase activity in a Nigerian population.

Authors:  Ayorinde Adehin; Oluseye Oladotun Bolaji
Journal:  Eur J Clin Pharmacol       Date:  2015-05-05       Impact factor: 2.953

3.  High CYP2A6 enzyme activity as measured by a caffeine test and unique distribution of CYP2A6 variant alleles in Ethiopian population.

Authors:  Eleni Aklillu; Natasa Djordjevic; Juan Antonio Carrillo; Eyasu Makonnen; Leif Bertilsson; Magnus Ingelman-Sundberg
Journal:  OMICS       Date:  2013-12-31

4.  In vivo evaluation of CYP2A6 and xanthine oxidase enzyme activities in the Serbian population.

Authors:  Natasa Djordjevic; Juan Antonio Carrillo; Guillermo Gervasini; Slobodan Jankovic; Eleni Aklillu
Journal:  Eur J Clin Pharmacol       Date:  2010-02-13       Impact factor: 2.953

5.  Phenotyping of N-acetyltransferase type 2 and xanthine oxidase with caffeine: when should urine samples be collected?

Authors:  Alexander Jetter; Martina Kinzig; Michael Rodamer; Dorota Tomalik-Scharte; Fritz Sörgel; Uwe Fuhr
Journal:  Eur J Clin Pharmacol       Date:  2008-12-13       Impact factor: 2.953

6.  Determination of Urinary Caffeine Metabolites as Biomarkers for Drug Metabolic Enzyme Activities.

Authors:  Hyeong Jun Kim; Min Sun Choi; Shaheed Ur Rehman; Young Seok Ji; Jun Sang Yu; Katsunori Nakamura; Hye Hyun Yoo
Journal:  Nutrients       Date:  2019-08-19       Impact factor: 5.717

7.  Disordered Glucose Levels Are Associated with Xanthine Oxidase Activity in Overweight Type 2 Diabetic Women.

Authors:  Maria Elena Hernandez-Hernandez; Enrique Torres-Rasgado; Patricia Pulido-Perez; Leticia Nicolás-Toledo; Margarita Martínez-Gómez; Jorge Rodríguez-Antolín; Ricardo Pérez-Fuentes; Jose R Romero
Journal:  Int J Mol Sci       Date:  2022-09-23       Impact factor: 6.208

8.  Evaluation of vanillin as a probe drug for aldehyde oxidase and phenotyping for its activity in a Western Indian Cohort.

Authors:  Sandhya Subash; Nithya J Gogtay; Krishna R Iyer; Prajakta Gandhe; Ritu Budania; Urmila M Thatte
Journal:  Indian J Pharmacol       Date:  2021 May-Jun       Impact factor: 1.200

9.  N-Acetyltransferase-2 (NAT2) phenotype is influenced by genotype-environment interaction in Ethiopians.

Authors:  Eleni Aklillu; Juan Antonio Carrillo; Eyasu Makonnen; Leif Bertilsson; Natasa Djordjevic
Journal:  Eur J Clin Pharmacol       Date:  2018-03-27       Impact factor: 2.953

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.